Tokyo, February 21, 2005 --- NEC Corporation ("NEC") and the
National Institute of Advanced Industrial Science and Technology
("AIST") today announced that they have succeeded in the joint
development of basic technology for a minute sample
amount/high-speed protein analysis system, which is vital to the
realization of prompt diagnosis of diseases such as cancer through
high-speed retrieval and detection of disease-specific protein
using newly developed nanobiochips.
The main characteristics of this technology are as follows:
1) By carrying out separation of the isoelectric point and
molecular weight (two inherent characteristics of protein) on a
nanobiochip and mass spectrometer respectively, short-time analysis
of approximately one hour is achieved. This improves the analysis
speed by 20 times that of the conventional method (two-dimensional
gel electrophoresis).
2) As a compact chip is used in place of large amounts of gel, the
size of the sample amount required for analysis is cut to one
twentieth that of the conventional method.
3) Comparison with the conventional method is easily enabled as a
two-dimensional map can be acquired from the two axes, the
isoelectric point and molecular weight.
This system is composed of nanobiochips and a MALDI TOF mass
spectrometer (*Note 1), and is realized by developing a special
chip structure that enables laser irradiation after isoelectric
electrophoresis (*Note 2) and a method for drying and immobilizing
protein in a separated state. Using this system, protein sample
separation using isoelectric electrophoresis inside the fluid
channel on the chip is carried out, the protein is then dried and
immobilized in a state of separation, and using the isoelectric
point and molecular weight protein contained in a minute sample
amount can be sorted at high-speed by direct laser irradiation on
the fluid channel. For example, through the quick detection of
characteristic protein in patients, giant leaps can be made in
improving the efficiency of the drug discovery process. Moreover,
as the existence of disease-specific protein can be quickly
detected by a minute sample amount, it is expected that this
technology can be applied to prompt diagnosis of diseases that
don't have a large effect on one's body.
As the sequence of a human genome (human gene) can be determined,
proteome analysis (*Note 3) is attracting attention as a
post-genomic analysis technology. With proteome analysis, protein
is the object for analysis, and as functional information relevant
to life activity, more so than genomic information, can be acquired
directly, application to genomic drug discovery (*Note 4) and
tailor-made medicine (*Note 5) can be expected. As a standard
proteome analysis technique to date, two-dimensional gel
electrophoresis (*Note 6) has been the conventional method used.
This is a method that uses the isoelectric point and molecular
weight to carry out two-dimensional separating and sorting of
protein within the structure.
It is well known that not only is protein within a tissue different
depending on the individual or organ, but also that it changes
immensely depending on the time. Although many samples are required
for proteome analysis, there is an issue with two-dimensional gel
electrophoresis as the throughput is inadequate. This is because
separation according to the isoelectric point and the molecular
weight are carried out through time-consuming gel electrophoresis
analysis. In addition, there is an issue in clinical application as
gel analysis requires a large amount of samples and this has a
large effect on the patient's body. From this, it is evident that
the development of next-generation proteome analysis technology, in
which the protein can be analyzed at an accelerated speed using
only a minute sample amount, is highly sought after.
NEC and AIST have been carrying out collaborative research to solve
these issues, and have succeeded in the development of minute
sample amount/high-speed protein analysis technology. NEC will
continue to carry out aggressive research in this area, positioning
it as next-generation proteome analysis technology within the bio
IT solutions business, toward its early realization. NEC announced
this research result at the 18th International Symposium in
Micro-Scale Bio-Separations on February 16th that was held in New
Orleans, Louisiana State, USA from February 11. In addition, NEC
will exhibit this technology at Nanotech 2005, which will be held
at Tokyo Big Sight, Japan from February 23.
Part of this research was aided by the New Energy and Industrial
Technology Development Organization ("NEDO") under the "Bionanochip
for the Analysis of Protein Interaction" project.
*Notes
1) Matrix-assisted laser disorption ionization time-of-flight mass
spectrometer. This is widely used in protein molecule analysis. 2)
Protein molecules have a specific ph (isoelectric point) at which
its net charge is zero. This method separates protein-mixture
samples under the electric field according to the isoelectric
points.
3) Method to comprehensively investigate proteins in the
tissue.
4) Drug discovery based on genomic information.
5) Medicine that takes into account each individuals responses to a
drug.
6) Gel-based separation method. Protein samples are sorted in a
two-dimensional manner: isoelectric point and molecular
weight.
|
About NEC Corporation
NEC is one of the world's leading providers of Internet,
broadband network and enterprise business solutions dedicated to
meeting the specialized needs of its diverse and global base of
customers. Ranked as one of the world's top patent-producing
companies, NEC delivers tailored solutions in the key fields of
computer, networking and electron devices, by integrating its
technical strengths in IT and Networks, and by providing advanced
semiconductor solutions through NEC Electronics Corporation. The
NEC Group employs more than 140,000 people worldwide and had net
sales of approximately $40 billion in the fiscal year ended March
2003. For additional information, please visit the NEC home page
at: http://www.nec.com/
|
Media Contacts